Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-20-003934

Director acquired 17,007 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fishman Mark Director 2020-02-10 Conversion +17,007 17,007 D
Derivatives
Fishman Mark Director 2020-02-10 Conversion · Series A-1 Preferred Stock −15,768 0 D
Fishman Mark Director 2020-02-10 Conversion · Series A-2 Preferred Stock −1,239 0 D
Loading xslF345X03/doc4.xml…